Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study - Wikidata - wikimedia - TriplyDB

Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study

Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study

http://www.wikidata.org/entity/Q30481797

about

Pharmacological treatment of PTSD - established and new approaches Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review Patient-reported outcomes in post-traumatic stress disorder. Part II: focus on pharmacological treatment Psychiatric disorders and sleep Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders Targeting memory processes with drugs to prevent or cure PTSD Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress Pathophysiological links between traumatic brain injury and post-traumatic headaches PTSD: from neurobiology to pharmacological treatments Sleep and REM sleep disturbance in the pathophysiology of PTSD: the role of extinction memory.The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder.A role for alpha-adrenergic receptors in extinction of conditioned fear and cocaine conditioned place preference Pharmacotherapy of PTSD: premises, principles, and priorities Initiation of pharmacotherapy for post-traumatic stress disorder among veterans from Iraq and Afghanistan: a dimensional, symptom cluster approach Pharmacological modulation of acute trauma memories to prevent PTSD: considerations from a developmental perspective Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders Best practice guide for the treatment of nightmare disorder in adults.Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Sleep disturbances as the hallmark of PTSD: where are we now?Relationships between mild traumatic brain injury sustained in combat and post-traumatic stress disorder The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress Disorder.A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress Post-traumatic stress disorder: emerging concepts of pharmacotherapy.Insomnia and the risk for suicide: does sleep medicine have interventions that can make a difference?Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.Diagnosis and management of sleep disorders in posttraumatic stress disorder:a review of the literature Sleep disturbances and their association with mental health among women exposed to intimate partner violence.Dissemination of CBTI to the non-sleep specialist: protocol development and training issues.Preclinical perspectives on posttraumatic stress disorder criteria in DSM-5.Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literature.Retrospective cross-validation of automated sleep staging using electroocular recording in patients with and without sleep disordered breathing.Sleep disturbances and PTSD: a perpetual circle?Treatment of nightmares with prazosin: a systematic review.Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials Pharmacotherapy of PTSD: Current Status and Controversies.Central hyperadrenergic state after lightning strike Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons A systematic review of cognitive-behavioral treatment for nightmares: toward a well-established treatment.

P2860

Q24633256-E2EE5935-7993-4950-B980-33AF371D1EEA Q24657469-0F0EC05F-A891-4EB8-988F-FE1F28F9ED5A Q26829332-5BBA5CA7-5398-423B-992B-89AC11852FCE Q27007685-BFD612CA-59DF-4947-9D62-BC754D221CB0 Q27009995-4253F6FD-A986-435C-ADC8-7E76B042EB2D Q27016155-0D457B8C-D24F-460C-9EAA-08B83B9AB42B Q27022219-54A56793-2BAC-44E7-A91F-8AA37D0662DF Q28067288-5A39519B-B3C3-47BC-B55F-8B3F60FECEC2 Q28070159-33332E40-573F-402D-9DA4-D727AAD18AAA Q30410039-0AE38C96-1A8C-4200-A7D4-9CFC268B9A3F Q30450972-8DC3BF3F-4FA4-47DA-BE5B-667A5257CF96 Q30475995-19F7B025-4A4E-43D1-9C4D-64BA05D5A9A9 Q30479154-95DF59E3-E22F-4F8C-B4A1-C3B282A58576 Q30490124-AA0FBCC9-8FAF-4953-A1CF-BB2DE4FB8280 Q33734824-A5F3B856-E715-4A9F-A3D2-00A52C9B590A Q33736941-6E568BA3-9CF9-4D74-9D4B-DA3AFAE850D6 Q34058202-F510B145-48FB-4F3D-A138-0278849FC46B Q34122994-48410D75-51AD-4C9E-BD66-D36ABA32C95F Q34253787-CA5955F0-A720-4654-BF4D-A5B6A4F7E343 Q34342884-CEAFF239-7921-45B4-B0E0-E981CF8C8A11 Q34343485-977FA3F9-55B0-4FF4-9A15-C7570F982649 Q34571585-2C142346-496F-478F-AE63-CF446A96F049 Q34669057-7AEACBB1-7035-4EBA-BB2F-F09E2080B698 Q34697445-35293FD2-3AFE-421F-96DB-520DBB304BE6 Q34981801-B486A906-80FF-4592-95E4-3CB47D56933A Q35020963-785BC9D0-DDF1-4CD1-B91A-4AF993FC2613 Q35028276-A92315A4-DA38-43E1-BB2F-24344701E217 Q35219862-E70B12C0-F01F-487D-ADDE-FA0FA9DE4002 Q35610383-C3FA9886-7CB6-4E77-975D-E4BFFED587A0 Q35849927-8B44C21C-43FC-442E-9964-BA51BC8CE709 Q35972373-881DE665-EEB3-404B-A594-F80D66F76165 Q36182711-34A570F4-5D23-461A-93C1-0956C04C4F53 Q36217958-8E6550F9-CC75-44A3-9CE2-10040A571663 Q36298093-EEB8281D-8979-4F19-AF3C-7481A343DC6B Q36513104-E5EABFD0-C0B6-4579-9647-C7B4B474BF34 Q36777691-339841DD-6078-47F8-89BE-C3B30F8466B8 Q36829455-B5013BB6-DCCB-4DEE-B958-770FE7C92F1C Q37079646-03E2ECB5-E21A-4871-B5A2-8FCCCFA81CA4 Q37149325-99F2007D-DDDC-4D6B-B267-5ED9CF77ACA1 Q37293396-A5B4AA51-8B46-4AC2-B180-1F9A84F4BFDF

P2860

Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study

http://www.wikidata.org/entity/Q30481797

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Prazosin effects on objective ...... er: a placebo-controlled study

@ast

Prazosin effects on objective ...... er: a placebo-controlled study

@en

type

label

Prazosin effects on objective ...... er: a placebo-controlled study

@ast

Prazosin effects on objective ...... er: a placebo-controlled study

@en

prefLabel

Prazosin effects on objective ...... er: a placebo-controlled study

@ast

Prazosin effects on objective ...... er: a placebo-controlled study

@en

P1433

Q30481797-CB1E7463-9E31-4052-9C5E-058BF0A2817B

P1476

Q30481797-A24CFB59-CB08-4450-BAD0-29F40B4C1ACC

P2093

Q30481797-34B7FDFD-8CCD-4BEF-B2A7-A17ABB29304D

Q30481797-63DD8330-D533-4024-8D74-41CEB0BE282D

Q30481797-64186011-B1E2-4439-BA7F-089FB901D07F

Q30481797-8914C28C-F89E-4C75-B0D9-0F32FF8211CA

Q30481797-94DB9287-3BBA-4908-B1F7-6932F6F7D809

Q30481797-A7287648-5EF5-49D8-8458-D27A66A84005

Q30481797-AA511EE0-A5DD-4146-9B45-9E8D465577BB

Q30481797-DB6DA6DE-5326-42DF-ABD6-9659A224E835

P2860

Q30481797-0159D761-F491-432D-BD35-D1242F17E0C5

Q30481797-056C112C-28B3-4A44-8C26-214364ABC7F8

Q30481797-0CE719E5-4BBD-4DE5-8AB2-5936232728CD

Q30481797-1BDA5D86-BC1C-46D5-BE08-F151598D5ED2

Q30481797-204EE22D-EDCD-4D5B-99DB-3D9491FB3F36

Q30481797-2149D8AA-6B6A-4573-8DE2-CE932A16228A

Q30481797-215E4DF6-C974-46BB-855D-584960BE65D5

Q30481797-26B5E2A5-9942-4555-A557-446429EDDE36

Q30481797-2BC8C1BA-AAE0-4EF9-893C-0899C45B8D3B

Q30481797-3C2D8C71-B582-470E-BF0D-CB8EFE99318B

P304

Q30481797-64CB6636-6433-42A2-AADA-0C7C962DD05A

P31

Q30481797-6F15EF79-4803-451D-8596-C56B8CC33C29

P356

Q30481797-1717EE96-4BC5-4349-B191-9A1656C7DA08

P407

Q30481797-055B466C-4013-45D8-8F61-54351E320CE3

P433

Q30481797-38462092-8293-41E7-A4F2-7321DFDD50BE

P478

Q30481797-0648886C-6AA9-414C-8A6F-1D8E2E1CBB61

P577

Q30481797-2A04DC27-F265-474D-A040-75204295FEE1

P5875

Q30481797-51A1BAAE-99C6-4976-B8F2-AFDE3DF6AB76

P698

Q30481797-48F5DEF7-41CB-4901-9079-C0A378B94EAE

P921

Q30481797-92263554-5219-422B-934A-C69C32BD0D6D

Q30481797-CCC92DD5-8CE3-4C4D-B8AE-B6EC86E6FC4A

P932

Q30481797-C7436A77-E8BD-4C0A-B398-0B826E210C31

P356

J.BIOPSYCH.2007.07.001

P1433

Biological Psychiatry

P1476

Prazosin effects on objective ...... er: a placebo-controlled study

@en

P2093

Charles Thompson

http://www.w3.org/2001/XMLSchema#string

Christopher Gross

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Fletcher B Taylor

http://www.w3.org/2001/XMLSchema#string

Judi Williams

http://www.w3.org/2001/XMLSchema#string

Murray A Raskind

http://www.w3.org/2001/XMLSchema#string

Patti Martin

http://www.w3.org/2001/XMLSchema#string

Thomas A Mellman

http://www.w3.org/2001/XMLSchema#string

P2860

CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison

Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review.

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.

The development of a Clinician-Administered PTSD Scale.

Future pharmacotherapy for post-traumatic stress disorder: prevention and treatment.

Sleep disturbance as the hallmark of posttraumatic stress disorder.

Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.

The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.

A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.

P304

629-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2007.07.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5971390

http://www.w3.org/2001/XMLSchema#string

P698

17868655

http://www.w3.org/2001/XMLSchema#string

P921

P932

2350188

http://www.w3.org/2001/XMLSchema#string